Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 20, Issue 4, pp. 716-725
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 16, 2020
- Revision received October 29, 2020
- Accepted January 27, 2021
- Published first February 3, 2021.
Article Versions
- Previous version (February 3, 2021 - 16:48).
- Previous version (February 5, 2021 - 09:42).
- Previous version (March 17, 2021 - 09:15).
- You are viewing the most recent version of this article.
Copyright & Usage
©2021 American Association for Cancer Research.
Author Information
- Amy A. Lo,
- Jennifer Johnston,
- Ji Li,
- Danielle Mandikian,
- Maria Hristopoulos,
- Robyn Clark,
- Dorothee Nickles,
- Wei-Ching Liang,
- Kathy Hötzel,
- Debra Dunlap,
- Thinh Pham,
- Hao Cai,
- Meric Ovacik,
- Daniel Bravo-Perez,
- Elaine Mai,
- Dionysos Slaga,
- Diego Ellerman,
- James Ziai,
- Klara Totpal,
- Genee Lee,
- C. Andrew Boswell,
- Jian Payandeh,
- Yan Wu, and
- Teemu T. Junttila*
- ↵*Corresponding Author:
Teemu T. Junttila, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080. E-mail: junttila.teemu{at}gene.com
April 2021
Volume 20, Issue 4
Volume 20, Issue 4
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Jump to section
Advertisement